Ultrasound Comes Of Age
Traditionally, there has been little interest among multi-modality imaging companies in having ultrasound technology among their product offerings. But the economic pressures of the current health care environment have forced even the leading imaging companies to take a second look at ultrasound. This turnabout is reflected in Philips's acquisition of ATL Ultrasound Inc., the leader in digital ultrasound.
You may also be interested in...
Just three years after its founding, Chinese cell therapy developer IASO Bio already has two assets in clinical development and the Nanjing firm has recently attracted $60m in financing. In an exclusive interview, its R&D head told Scrip that speed and partnerships are propelling Chinese developers on a trajectory to quickly catch up with the west in the emerging cell-therapy arena.
Updated guidance from England’s National Institute for Health and Care Excellence says two neurostimulation systems for treatment-resistant depression and epilepsy should only be used under special conditions. See what LivaNova’s VP of difficult-to-treat depression, Jonathan Walker, said about it here.